Search Orphan Drug Designations and Approvals
-
Generic Name: | Human Anti-tumor Necrosis factor alpha monoclonal antibody |
---|---|
Date Designated: | 01/16/2003 |
Orphan Designation: | Treatment of uveitis of the posterior segment of non-infectious etiology, and uveitis of the anterior segment of non-infectious etiology and refractory to conventional therapy |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Centocor, Inc. 200 Great Valley Parkway Malvern, Pennsylvania 19355 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-